Found: 2
Select item for more details and to access through your institution.
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 401, p. 1, doi. 10.1126/scitranslmed.aam7049
- By:
- Publication type:
- Article
A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study.
- Published in:
- BMC Cancer, 2007, v. 7, p. 39, doi. 10.1186/1471-2407-7-39
- By:
- Publication type:
- Article